NCT02028286View on ClinicalTrials.gov

A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

March 31, 2014

Conditions
Papulopustular Rosacea
Interventions
DRUG

CLS001

Trial Locations (2)

07601

Frontage Clinical Services, Hackensack

Unknown

Derm Research, Austin

All Listed Sponsors
lead

Maruho Co., Ltd.

INDUSTRY

NCT02028286 - A 21 Day Pharmacokinetics Study in Papulopustular Rosacea | Biotech Hunter | Biotech Hunter